SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-061992
Filing Date
2023-11-09
Accepted
2023-11-09 16:03:47
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inab-20231109.htm   iXBRL 8-K 50288
2 EX-99.1 inab-ex99_1.htm EX-99.1 215516
3 GRAPHIC img75407775_0.jpg GRAPHIC 7265
  Complete submission text file 0000950170-23-061992.txt   410279

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inab-20231109.xsd EX-101.SCH 2451
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inab-20231109_lab.xml EX-101.LAB 14018
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inab-20231109_pre.xml EX-101.PRE 10275
8 EXTRACTED XBRL INSTANCE DOCUMENT inab-20231109_htm.xml XML 4926
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 231392214
SIC: 2836 Biological Products, (No Diagnostic Substances)